James Mackaness, CFO and COO at Iridex, holds 119.17K shares in Soleno Therapeutics (Ticker: SLNO), holds 0.00 shares in Invuity (Ticker: IVTY), holds 45.05K shares in Iridex (Ticker: IRIX). Most recently, James Mackaness Sold ― shares of Soleno Therapeutics on Oct 03, 2024 for an estimated value of 399.19K.
What is the percentage of profitable transactions made by James Mackaness?
The percentage of profitable transactions made by James Mackaness is 13%.
What is the average return per transaction made by James Mackaness?
The average return per transaction made by James Mackaness is -46.70%.
What stocks does James Mackaness hold?
James Mackaness holds: IRIX, SLNO, IVTY stocks.
What was James Mackaness’s latest transaction?
James Mackaness latest transaction was an Informative Sell of $399.19K.
What was James Mackaness's most profitable transaction?
James Mackaness’s most profitable transaction was an Informative Buy of IVTY stock on May 19, 2016. The return on the trade was 50.90%.
What is James Mackaness's role in Iridex?
James Mackaness's role in Iridex is CFO and COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.